47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The p.R92W variant of NR5A1/Nr5a1 induces testicular development of 46,XX gonads in humans, but not in mice: phenotypic comparison of human patients and mutation-induced mice

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          NR5A1 is the key regulator of adrenal and gonadal development in both humans and mice. Recently, a missense substitution in human NR5A1, p.R92W, was shown to underlie gonadal dysgenesis in genetic males and testicular formation in genetic females. Here, we investigated the phenotypic effects of the p.R92W mutation on murine development. Mice carrying the p.R92W mutation manifested a similar but milder phenotype than that of the previously described Nr5a1 knockout mice. Importantly, mutation-positive XX mice showed no signs of masculinization. These results, together with prior observations, indicate that the p.R92W mutation in NR5A1/Nr5a1 encodes unique molecules that disrupt male gonadal development in both humans and mice and induces testicular formation specifically in human females. Our findings provide novel insights into the conservation and divergence in the molecular networks underlying mammalian sexual development.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Rapid generation of mouse models with defined point mutations by the CRISPR/Cas9 system

          Introducing a point mutation is a fundamental method used to demonstrate the roles of particular nucleotides or amino acids in the genetic elements or proteins, and is widely used in in vitro experiments based on cultured cells and exogenously provided DNA. However, the in vivo application of this approach by modifying genomic loci is uncommon, partly due to its technical and temporal demands. This leaves many in vitro findings un-validated under in vivo conditions. We herein applied the CRISPR/Cas9 system to generate mice with point mutations in their genomes, which led to single amino acid substitutions in proteins of interest. By microinjecting gRNA, hCas9 mRNA and single-stranded donor oligonucleotides (ssODN) into mouse zygotes, we introduced defined genomic modifications in their genome with a low cost and in a short time. Both single gRNA/WT hCas9 and double nicking set-ups were effective. We also found that the distance between the modification site and gRNA target site was a significant parameter affecting the efficiency of the substitution. We believe that this is a powerful technique that can be used to examine the relevance of in vitro findings, as well as the mutations found in patients with genetic disorders, in an in vivo system.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Steroidogenic factor-1 (SF-1, NR5A1) and human disease

            Steroidogenic factor-1 (SF-1, Ad4BP, encoded by NR5A1) is a key regulator of adrenal and reproductive development and function. Based upon the features found in Nr5a1 null mice, initial attempts to identify SF-1 changes in humans focused on those rare individuals with primary adrenal failure, a 46,XY karyotype, complete gonadal dysgenesis and Müllerian structures. Although alterations affecting DNA-binding of SF-1 were found in two such cases, disruption of SF-1 is not commonly found in patients with adrenal failure. In contrast, it is emerging that variations in SF-1 can be found in association with a range of human reproductive phenotypes such as 46,XY disorders of sex development (DSD), hypospadias, anorchia, male factor infertility, or primary ovarian insufficiency in women. Overexpression or overactivity of SF-1 is also reported in some adrenal tumors or endometriosis. Therefore, the clinical spectrum of phenotypes associated with variations in SF-1 is expanding and the importance of this nuclear receptor in human endocrine disease is now firmly established.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              SF-1 a key player in the development and differentiation of steroidogenic tissues

              Since its discovery in the early 1990s, the orphan nuclear receptor SF-1 has been attributed a central role in the development and differentiation of steroidogenic tissues. SF-1 controls the expression of all the steroidogenic enzymes and cholesterol transporters required for steroidogenesis as well as the expression of steroidogenesis-stimulating hormones and their cognate receptors. SF-1 is also an essential regulator of genes involved in the sex determination cascade. The study of SF-1 null mice and of human mutants has been of great value to demonstrate the essential role of this factor in vivo, although the complete adrenal and gonadal agenesis in knock-out animals has impeded studies of its function as a transcriptional regulator. In particular, the role of SF-1 in the hormonal responsiveness of steroidogenic genes promoters is still a subject of debate. This extensive review takes into account recent data obtained from SF-1 haploinsufficient mice, pituitary-specific knock-outs and from transgenic mice experiments carried out with SF-1 target gene promoters. It also summarizes the pros and cons regarding the presumed role of SF-1 in cAMP signalling.
                Bookmark

                Author and article information

                Contributors
                miyado-m@ncchd.go.jp
                inui-m@ncchd.go.jp
                igarashi-m@ncchd.go.jp
                fukui-y@ncchd.go.jp
                kei11takasawa@hotmail.com
                akos@mub.biglobe.ne.jp
                junkokan@ya2.so-net.ne.jp
                kkashimada.ped@tmd.ac.jp
                miyado-k@ncchd.go.jp
                tamanom@adm.h.u-tokyo.ac.jp
                tomogata@hama-med.ac.jp
                takada-s@ncchd.go.jp
                fukami-m@ncchd.go.jp
                Journal
                Biol Sex Differ
                Biol Sex Differ
                Biology of Sex Differences
                BioMed Central (London )
                2042-6410
                8 November 2016
                8 November 2016
                2016
                : 7
                : 56
                Affiliations
                [1 ]Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, 157-8535 Japan
                [2 ]Department of Systems BioMedicine, National Research Institute for Child Health and Development, Tokyo, 157-8535 Japan
                [3 ]Department of Reproductive Biology, National Research Institute for Child Health and Development, Tokyo, 157-8535 Japan
                [4 ]Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, 113-8510 Japan
                [5 ]Department of Endocrinology, Miyagi Children’s Hospital, Sendai, 989-3126 Japan
                [6 ]Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192 Japan
                Article
                114
                10.1186/s13293-016-0114-6
                5101639
                27833742
                5f74283c-f0aa-40fd-954e-c9e8074101cd
                © The Author(s). 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 29 July 2016
                : 1 November 2016
                Funding
                Funded by: the Japan Agency for Medical Research and Development
                Funded by: the National Center for Child Health and Development
                Funded by: the Takeda foundation
                Funded by: the Ministry of Education, culture, Sports, Science and Technology
                Categories
                Letter to the Editor
                Custom metadata
                © The Author(s) 2016

                Human biology
                disorders of sex development,genome editing,gonadal development,gonadal dysgenesis,mouse model,mutation,sex differentiation,sf-1

                Comments

                Comment on this article